Arkolith/Insider Trading/TECH/Form 4

Baumgartner Robert V

DirectorBIO-TECHNE Corp (TECH) · full profile →Form 4 · filed Aug 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$958K
Net Open-Market Flow
-$958K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 25, 2025Option exercise(M)17K$21.84$372K62K
Aug 25, 2025Sell(S)17K$56.21$958K45K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 25, 2025Option exercise(M)17K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-014992) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML